Skip to content

Deferred Revenue at other companies

Alumis Inc. logo
Alumis Inc.ALMS
$6.33M
ALN
Alnylam PharmaceuticalsALNY
$3.21M-88.6%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$621K+515%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.12M-65.1%
Alkermes logo
AlkermesALKS
$0-100%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$69.2M-14.7%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%
Enterprise value$2.44B+78.3%
P/E-25.6×
P/S+2.6×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's deferred revenue?
Aurinia Pharmaceuticals (AUPH) reported deferred revenue of $5.04M in Q1 2026.
How has Aurinia Pharmaceuticals's deferred revenue changed year-over-year?
Aurinia Pharmaceuticals's deferred revenue increased by 9.6% year-over-year, from $4.59M to $5.04M.
What is the long-term trend for Aurinia Pharmaceuticals's deferred revenue?
Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's deferred revenue has grown at a 110.4% compound annual growth rate (CAGR), from $190K to $3.72M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.